bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in bluebird bio, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +21 vs. Q3 2023
- Shares held
- 130.6M
- +40.9M (+45.7%) vs. Q3 2023
- Total value
- $180.2M
- −$92.3M (−33.9%) vs. Q3 2023
- New holders
- 55
- 64 more added
- Sold out
- 34
- 39 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $6.89K |
| Q1 2025 | 85 | $17.1M |
| Q4 2024 | 83 | $23.8M |
| Q3 2024 | 140 | $32.9M |
| Q2 2024 | 152 | $77.2M |
| Q1 2024 | 159 | $131.6M |
| Q4 2023 | 188 | $180.2M |
| Q3 2023 | 170 | $272.7M |
| Q2 2023 | 177 | $308.6M |
| Q1 2023 | 180 | $309.5M |
| Q4 2022 | 186 | $470.5M |
| Q3 2022 | 163 | $414.9M |
| Q2 2022 | 156 | $227.9M |
| Q1 2022 | 178 | $300.5M |
| Q4 2021 | 176 | $581.9M |
| Q3 2021 | 200 | $996.6M |
| Q2 2021 | 235 | $1.70B |
| Q1 2021 | 235 | $1.58B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding bluebird bio, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −48,666−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −40,598−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −30,298−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −30,220−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −27,967−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −21,261−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −15,208−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −12,972−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,305−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −10,376−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −3,860−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −3,685−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −1,605−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Earnest Partners LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −2,025−100.0% | Sold out |
| Colony Group LLC | – | – | – | – | Not filed |
| Connacht Asset Management LP | – | – | – | – | Not filed |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |